1. Home
  2. CCC vs BLLN Comparison

CCC vs BLLN Comparison

Compare CCC & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCC Intelligent Solutions Holdings Inc.

CCC

CCC Intelligent Solutions Holdings Inc.

N/A

Current Price

$4.95

Market Cap

3.6B

Sector

Technology

ML Signal

N/A

BLLN

BillionToOne Inc.

N/A

Current Price

$80.12

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCC
BLLN
Founded
1980
2016
Country
United States
United States
Employees
2185
713
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CCC
BLLN
Price
$4.95
$80.12
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$9.44
$126.71
AVG Volume (30 Days)
9.2M
281.7K
Earning Date
04-30-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.22
$45.96
Revenue Next Year
$8.58
$30.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.81
$61.96
52 Week High
$8.68
$138.70

Technical Indicators

Market Signals
Indicator
CCC
BLLN
Relative Strength Index (RSI) 29.23 51.76
Support Level $4.81 $80.39
Resistance Level $6.40 $83.20
Average True Range (ATR) 0.29 6.77
MACD -0.09 1.35
Stochastic Oscillator 3.50 49.68

Price Performance

Historical Comparison
CCC
BLLN

About CCC CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: